文献速递眼底病与葡萄膜炎

糖尿病性黄斑水肿玻璃体内地塞米松植入剂治疗后中心凹下脉络膜厚度变化

CHANGES IN SUBFOVEAL CHOROIDAL THICKNESS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT THERAPY FOR DIABETIC MACULAR EDEMA.
PubMed 文献 · Retina · 2021-01-01

结果显示基线SFCT在7周和14周显著下降,SFCT降低与黄斑中心厚度(CMT)减少及视力改善相关,且良好功能和解剖应答眼SFCT下降更显著。

要点

  • 地塞米松植入剂治疗后SFCT在7周和14周均显著降低(P<0.001)。
  • CMT每减少1µm,7周时SFCT降低0.09µm(P=0.002),14周时降低0.14µm(P<0.001)。
  • 7周时视力每提高5个ETDRS字母,SFCT降低3.91µm(P=0.044)。

核心结论

  • 糖尿病性黄斑水肿经地塞米松植入剂治疗后SFCT变化可能预测解剖和功能结局,并与已知治疗应答预测OCT特征相关。

主要发现

  • 平均基线SFCT在第7周(P<0.001)和第14周(P<0.001)显著下降。
  • 第7周时,CMT每减少1µm与SFCT降低0.09µm相关(P=0.002),视力改善5个ETDRS字母(-0.1 logMAR)与SFCT降低3.91µm相关(P=0.044)。
  • 第14周时,CMT每减少1µm与SFCT降低0.14µm相关(P<0.001)。
  • 功能和和解剖应答良好的眼SFCT下降更显著。
  • 第7周时,视网膜下液导致更大的SFCT变化(P=0.039)和更好的BCVA(P=0.033)。

临床怎么用

  • 地塞米松植入剂治疗糖尿病性黄斑水肿后,监测SFCT变化可能有助于预判解剖和功能治疗应答。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate changes in subfoveal choroidal thickness (SFCT) and their relationship with best-corrected visual acuity and optical coherence tomography parameters after intravitreal dexamethasone implant injection for diabetic macular edema. METHODS: Eighty-one eyes treated with dexamethasone implant injection for diabetic macular edema were evaluated for best-corrected visual acuity, central macular thickness, SFCT, and optical coherence tomography parameters at baseline and Weeks 7 and 14. RESULTS: The mean baseline SFCT significantly decreased at Weeks 7 (P < 0.001) and 14 (P < 0.001). At Week 7, each 1-µm reduction in central macular thickness and five Early Treatment Diabetic Retinopathy Study letters (-0.1 logarithm of the minimal angle of resolution) improvement were associated with SFCT reductions of 0.09 (P = 0.002) and 3.91 (P = 0.044) µm, respectively. At Week 14, each 1-µm reduction in central macular thickness was associated with a 0.14-µm reduction in SFCT (P < 0.001). Eyes with good functional and anatomical responses exhibited significantly greater SFCT reductions. Subretinal fluid resulted in greater SFCT changes (P = 0.039) and better best-corrected visual acuity (P = 0.033) at Week 7. A continuous ellipsoid zone/interdigitation zone layer was associated with a smaller mean SFCT at Week 7 (P = 0.002) and better best-corrected visual acuity at Weeks 7 and 14 (both, P < 0.001). CONCLUSION: Changes in SFCT after dexamethasone implant injection therapy for diabetic macular edema may predict anatomical and functional outcomes and correlate with optical coherence tomography features that are known as predictors of treatment response.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Moon KY, Choi SY, Song JH, et al. CHANGES IN SUBFOVEAL CHOROIDAL THICKNESS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT THERAPY FOR DIABETIC MACULAR EDEMA. Retina. 2021. PMID: 33323903. doi:10.1097/IAE.0000000000003029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。